Stira Pharmaceuticals
Fairfield, NJ, United States stirapharma.com
From their website, Nov 2026
Work here? Claim this listing
- GMP
About
Stira Pharmaceuticals is a U.S.-based CDMO in Fairfield, New Jersey focused on sterile injectable drug products. It provides analytical, development, and cGMP manufacturing services for small molecules, peptides, oligonucleotides, and large molecules including biosimilars, for clinical and commercial programs.
Services
Contract analytical services
Provides deep analytical expertise for peptides, small molecules, oligonucleotides, and biosimilars.
Assays & in vitro testing
Analytical testing
Offers standalone analytical testing for small molecules, peptides, biologics, biosimilars, and oligonucleotides.
Assays & in vitro testing
Analytical method development and validation
Develops, validates, and transfers analytical methods for APIs, excipients, and drug products.
Assays & in vitro testing
Preformulation
Performs pharmaceutical profiling and preformulation studies for molecules.
Extractables and leachables studies
Conducts extractables and leachables evaluations for packaging, container-closure, and label migration studies.
Assays & in vitro testing
In vitro permeability testing (IVPT)
Provides IVPT method development and validation.
Assays & in vitro testing
In vitro release testing (IVRT)
Provides IVRT method development and validation and drug release profiling.
Assays & in vitro testing
In vitro biowaiver studies
Offers in vitro biowaiver studies.
Assays & in vitro testing
Stability testing
Runs stability studies including photostability and freeze-thaw stability.
Assays & in vitro testing
Clinical manufacturing
Supports clinical manufacturing of sterile injectables.
CDMO: development & manufacturing
Commercial manufacturing
Supports commercial manufacturing of sterile injectables.
CDMO: development & manufacturing
Microbiology testing
Performs compendial and non-compendial microbiology testing.
Assays & in vitro testing
Regulatory support
Provides regulatory support for product development and commercialization.
Product development
Provides end-to-end engineering, manufacturing, and quality operations for sterile injectable development.
Cell-based assays
Offers cell-based assays including bio-assays and immunogenicity testing.
Assays & in vitro testing
Capabilities
- Assays and studies
- Oligonucleotides · Peptides · Small molecules · Stability studies · Cell-based assays · Analytical development · Advanced structural and physicochemical characterization · Commercial testing and release · In vitro biowaiver studies · Iron complex product sameness testing · Nitrosamine testing · Small molecule and peptide testing and sameness studies
8 more
Oligonucleotides (ASO) testing · Biosimilar product testing · Drug-device combination product testing · Extractables and leachables · Microbiology (USP/BAM and non-compendial) · API characterization · Assay testing · Related substances testing - Scale and capacity
- Batch sizes up to ~2000L · Three injectable robotic fill-and-finish lines · Three aseptic fill-and-finish lines · Triple Combi Filling Machine: ~9000 UPH · Robotic IV Bag Filling & Sealing Machine: ~1200 UPH · Double Combi Filling Machine with Lyophilization: ~6000 or ~12,500 UPH · Single-Use Mixing Tanks (50L–2000L) · ~88,000 sq.ft. facility
Instruments and platforms
- HPLC
- GC-MS
- LC-MS
- FT-IR
- ICP
- GPC
- IC
- X-RPD
- DSC
- TGA
Modalities and species
- Modalities
- Small molecule · Peptide · Oligonucleotide · Biosimilar
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Company
- Type
- CRDMO
Locations
- Address
- 161 Dwight Place, Fairfield, NJ 07004
- Sites
- Fairfield, USA
- Serves
- U.S. market
Public records
- FDA drug establishment registration
- 3017224277 · ANALYSIS; MANUFACTURE; PACK source
Similar labs
Work here? Claim this listing